Heart rate variability as a measure of pain intensity in patients with cancer-related pain.

Recruiting

• Conditions: Patients with malignancy visiting our outpatient clinic who have a pain intensity of at least 5 on a visual analogue scale (ranging from 0-10) can be included.

• Registration Number: NL-OMON20253
• Lead Sponsor: MCG

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

1. Patients with known metastatic malignancy;

2. Patients with a pain intensity of at least 5 on a visual analogue pain scale;

Exclusion Criteria

1. Patients with neuropathic pain;

2. Patients using medication that interferes with HRV;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correlation between the pain intensity as measured by the visual analogue scale and as measured by heart rate variability.

Secondary Outcome Measures

Name	Time	Method
1. Correlation between the response to pain medication using the visual analogue scale and the EORTC QLQ-C30 questionnairel;<br /><br>2. correlation between the response to pain medication using heart rate variability measures and the EORTC QLQ-C30 questionnaire.